JP2024508334A5 - - Google Patents
Info
- Publication number
- JP2024508334A5 JP2024508334A5 JP2023553354A JP2023553354A JP2024508334A5 JP 2024508334 A5 JP2024508334 A5 JP 2024508334A5 JP 2023553354 A JP2023553354 A JP 2023553354A JP 2023553354 A JP2023553354 A JP 2023553354A JP 2024508334 A5 JP2024508334 A5 JP 2024508334A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- level
- composition according
- lomitapide
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163155960P | 2021-03-03 | 2021-03-03 | |
| US63/155,960 | 2021-03-03 | ||
| US202163165457P | 2021-03-24 | 2021-03-24 | |
| US63/165,457 | 2021-03-24 | ||
| PCT/US2022/018672 WO2022187463A1 (en) | 2021-03-03 | 2022-03-03 | Methods for treating familial chylomicronemia syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508334A JP2024508334A (ja) | 2024-02-26 |
| JP2024508334A5 true JP2024508334A5 (cg-RX-API-DMAC7.html) | 2026-05-18 |
Family
ID=80819670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023553354A Pending JP2024508334A (ja) | 2021-03-03 | 2022-03-03 | 家族性高カイロミクロン血症症候群を治療するための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240165093A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4301361A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024508334A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230153375A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022231007A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023016943A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3208189A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL305191A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023010297A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022187463A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112023000808A2 (pt) | 2020-07-29 | 2023-02-07 | Amryt Pharmaceuticals Inc | Lomitapida para uso em métodos para tratar hiperlipidemia e hipercolesterolemia em pacientes pediátricos |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595872A (en) | 1992-03-06 | 1997-01-21 | Bristol-Myers Squibb Company | Nucleic acids encoding microsomal trigyceride transfer protein |
| US5883109A (en) | 1996-07-24 | 1999-03-16 | Bristol-Myers Squibb Company | Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug |
| US6066653A (en) | 1997-01-17 | 2000-05-23 | Bristol-Myers Squibb Co. | Method of treating acid lipase deficiency diseases with an MTP inhibitor and cholesterol lowering drugs |
| PT1725234E (pt) | 2004-03-05 | 2013-03-04 | Univ Pennsylvania | Métodos com efeitos secundários reduzidos para tratamento de patologias ou doenças associadas a hiperlipidemia e hipercolesterolemia |
| BR102015025502B1 (pt) | 2015-04-30 | 2022-06-21 | Aegerion Pharmaceuticals, Inc | Composição de lomitapida, tablete, produto de lomitapida, métodos para analisar uma composição de amostra de lomitapida e para determinar uma quantidade de uma impureza em uma amostra da composição |
-
2022
- 2022-03-03 JP JP2023553354A patent/JP2024508334A/ja active Pending
- 2022-03-03 KR KR1020237028890A patent/KR20230153375A/ko active Pending
- 2022-03-03 BR BR112023016943A patent/BR112023016943A2/pt unknown
- 2022-03-03 CA CA3208189A patent/CA3208189A1/en active Pending
- 2022-03-03 US US18/548,798 patent/US20240165093A1/en active Pending
- 2022-03-03 EP EP22711788.4A patent/EP4301361A1/en active Pending
- 2022-03-03 WO PCT/US2022/018672 patent/WO2022187463A1/en not_active Ceased
- 2022-03-03 AU AU2022231007A patent/AU2022231007A1/en active Pending
- 2022-03-03 MX MX2023010297A patent/MX2023010297A/es unknown
- 2022-03-03 IL IL305191A patent/IL305191A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Grote Beverborg et al. | Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy | |
| EP3435996B1 (en) | Elafibranor for use in the treatment of primary biliary cholangitis | |
| CN110520125A (zh) | 治疗肝病的方法 | |
| Yampolsky et al. | Augmentation of myocardial If dysregulates calcium homeostasis and causes adverse cardiac remodeling | |
| JP7830313B2 (ja) | アルコール性肝炎の処置 | |
| US11331292B2 (en) | Methods of treatment of cholestatic diseases | |
| US12310935B2 (en) | Methods of treatment of cholestatic diseases | |
| JP2023501457A5 (cg-RX-API-DMAC7.html) | ||
| JP7756126B2 (ja) | 脂肪性肝疾患の治療薬 | |
| Nakayama et al. | Dilated cardiomyopathy with eosinophilic granulomatosis with polyangiitis in which active myocardial inflammation was only detected by endomyocardial biopsy | |
| JP2017519726A (ja) | リポジストロフィー治療用脂肪酸胆汁酸複合体 | |
| US20250281507A1 (en) | Methods of treating nephrotic syndrome | |
| JP2024508334A (ja) | 家族性高カイロミクロン血症症候群を治療するための方法 | |
| Sun et al. | Jinxinkang Granule Preserves Myocardial Function by Suppressing Cardiac Senescence Through the cGAS-STING Axis in a Pressure Overload Mouse Model of Heart Failure | |
| JP2020533353A (ja) | アルコール性肝炎の治療のためのil−1b結合抗体の使用 | |
| WO2026107045A1 (en) | Resmetirom for use in treating cardiomyopathy and/or related heart failure and portal hypertension | |
| WO2025224044A1 (en) | Methods of treatment of primary biliary cholangitis | |
| CN110099686B (zh) | 非酒精性脂肪性肝病的治疗 | |
| AU2024329780A1 (en) | Elafibranor for use in the treatment of primary biliary cholangitis | |
| HK40002034A (en) | Elafibranor for use in the treatment of primary biliary cholangitis | |
| HK40002034B (en) | Elafibranor for use in the treatment of primary biliary cholangitis | |
| HK40012462B (en) | Treatment of nonalcoholic fatty liver disease | |
| HK40012462A (en) | Treatment of nonalcoholic fatty liver disease |